Mundipharma’s k-haler wins design awards

Mundipharma’s k-haler breath-activated metered dose inhaler has won two platinum A’ Design Awards in the ‘Scientific Instruments, Medical Devices and Research Equipment Design’ and ‘Ease of Use and Universal Design’ categories.

In October 2017, the company’s Flutiform k-haler received marketing approval for the treatment of asthma through the European decentralized procedure.

Mundipharma Senior Commercial Lead Jonathan Marshall said, “We’re delighted that the k-haler device has received two awards recognizing its innovative design, developed with patients front of mind. Our hope is that it reduces the number of critical errors associated with inhaler device usage and therefore helps to improve long term outcomes for patients.”

Read the Mundipharma press release.

Share

published on

December 9-December 11: DDL 2026, Edinburgh, Scotland

April 27-30: RDD Europe 2027, Antibes, France

June 30: RespireX 2027, Boston, MA, USA